Expression of CD34, DOG1, S100 in CD117-negative and CD117-positive gastrointestinal stromal tumors with different potential of malignancy and clinical, morphological features

Authors

  • V. R. Skorik SE «Dnipropetrovsk Medical Academy of Health Ministry of Ukraine»,

DOI:

https://doi.org/10.14739/2310-1237.2015.3.55103

Keywords:

Stomасh Diseases, Neoplasms, Immunohistochemistry

Abstract

Diagnosis verification of gastrointestinal stromal tumor (GIST) requires thorough differential diagnosis and determination of malignancy potential.

Aim. In order to evaluate the relationship between clinical (patient age, localization of the primary tumor), morphological (histological type) and immunohistochemical (CD117status, Ki-67 index) data in GIST samples of 43 patient we studied the expression of markers DOG1, CD34, S100.

Methods and results. It was established, that S100-positive (+) cases are found in less than 5% of GIST, and CD34+ and DOG1+ in 81.4% and 86.6% respectively. Reliable relationship between characters of expression of CD34, DOG1 and clinical and morphological data was not detected (p> 0.05). The portion of cases of CD34-, DOG1- (50%) is dominant in groups with high Ki-67, and portion of CD34+, DOG1+ (40%, 40.9% respectively) - with low, but this relationship was not statistically confirmed (p > 0,05).

References

Hamilton, S. R., Aaltonen, L. A., Capella, C. (2000). World Health Organisation classificatoin of tumors. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press.

Odze, R. D., Goldblum, J. R., & Crawford, J. M. (2004). Surgical pathology of GI tract, liver, biliary tract, and pancreas. Pennsylvania: Elsevier.

Fletcher, C. D. M. (2013). Diagnostic histopathology of tumors. Philadelphia: Elsevier.

Ohnishi, H., Sasaki, H., Nakamura, Y., Kato, S., Ando, K., Narimatsu, H., & Tachibana, K. (2013). Regulation of cell shape and adhesion by CD34. Cell adhesion & migration, 7(5), 426-433. doi: 10.4161/cam.25957.

McNagny, K., Debruin, E., Gold, M., Bennett, J., Blanchet, M.-R., Maltby, S., & Hughes, M. (2012). CD34 family proteins are key regulators of inflammatory cell migration and vascular integrity. The Journal of Immunology, 188(Meeting Abstracts 1), 173–17.

Miettinen, M., & Lasota, J. (2011). Histopathology of gastrointestinal stromal tumor. Journal of surgical oncology, 104(8), 865–873. doi: 10.1002/jso.21945.

Nielsen, J. S., & McNagny, K. M. (2008). Novel functions of the CD34 family. Journal of cell science, 121(22), 3683–3692. doi: 10.1242/jcs.037507.

Hwang, D. G., Qian, X., & Hornick, J. L. (2011). DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. American journal of clinical pathology, 135(3), 448–453. doi: 10.1309/AJCP0PPKOBNDT9LB.

Wada, T., Tanabe, S., Ishido, K., Higuchi, K., Sasaki, T., Katada, C., & Mikami, T. (2013). DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach. World journal of gastroenterology: WJG, 19(47), 9133. doi: 10.3748/wjg.v19.i47.9133.

Ríos-Moreno, M. J., Jaramillo, S., Gallardo, S. P., Vallejo, A., Mora, M., García-Escudero, & González-Cámpora, R. (2012). Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Pathology-Research and Practice, 208(2), 74–81.

doi: 10.1016/j.prp.2011.11.006

Downloads

How to Cite

1.
Skorik VR. Expression of CD34, DOG1, S100 in CD117-negative and CD117-positive gastrointestinal stromal tumors with different potential of malignancy and clinical, morphological features. Pathologia [Internet]. 2015Dec.18 [cited 2024May16];(3). Available from: http://pat.zsmu.edu.ua/article/view/55103

Issue

No. 3 (2015)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).